© 1996 by Oxford University Press
Journal of the National Cancer Institute, Vol. 88, No. 18, 1285-1296,
September 18, 1996
© 1996 Oxford University Press
Reversal by Hyaluronidase of Adhesion-Dependent Multicellular Drug Resistance in Mammary Carcinoma Cells
Division of Cancer Biology Research, Sunnybrook Health Science Center, Reichmann Research Institute Toronto, ON, Canada and Department of Medical Biophysics, University of Toronto Toronto, ON, Canada
Department of Anatomy and Cell Biology, Queen's University Kingston, ON
Robert S. Kerbel, Ph.D., Division of Cancer Biology Research, Sunnybrook Health Science Center, Toronto-Sunnybrook Regional Cancer Center, S-218, 2075 Bayview Ave., Toronto, ON, Canada M4N 3M5.
BACKGROUND: De novo or acquired resistance to chemotherapeutic drugs continues to be one of the most important obstacles hindering the successful treatment of cancer patients. Consequently, enhancing the efficacy of conventional chemotherapeutic drugs has become an important research goal. Our previous studies using the mouse EMT-6 mammary carcinoma selected for resistance to various alkylating agents in vivo demonstrated that such acquired drug resistance may be manifested in vitro only in cells growing in a three-dimensional configuration but not in conventional monolayer culture. We also found that this phenomenon, which we refer to as "acquired multicellular resistance," is associated with an increase in intercellular adhesion or compaction of the alkylating agent-resistant cell lines grown as aggregates in three-dimensional culture.
PURPOSE: The present study further investigates the impact of three-dimensional architecture on acquired multicellular drug resistance and its influence on cell cycle kinetics, cell cycle arrest, and cell survival.
METHODS: To test the hypothesis that an increase in three-dimensional compaction is related to the drug resistance properties of the cells, we did the following: 1) selected clones of the EMT-6 cell line that spontaneously formed tightly or loosely adherent aggregates and assessed their respective drug resistance properties in vitro; 2) assayed tumorigenic potential of the tight and loose clones after exposure to defined concentrations of the activated form of cyclophosphamide, 4-hydroperoxycyclophos-phamide (4-HC) in vitro; and 3) treated the tight clones with hyaluronidase, an agent capable of disrupting EMT-6 spheroids, and assayed what effect this treatment had on chemosensitivity. We used fluorescence-activated cell sorter analysis to monitor any potential alterations in cell cycle kinetics.
RESULTS: The increase in compaction in three-dimensional culture was sufficient to confer resistance to 4-HC. This increase in intercellular adhesion was also associated with a lower proliferating fraction of tumor cells and with an almost completely diminished ability of the cells to arrest in the G2/M phase of the cell cycle after drug exposure. Furthermore, these changes were detectable only in three-dimensional culture, not in conventional monolayer culture. In conventional monolayer culture, all cell types consistently showed a high level of proliferation and arrested in G2/M after exposure to 4-HC. Moreover, hyaluronidase was able to disrupt intercellular adhesion and chemosensitize tumor cells both in vitro and in vivo in an ascites model.
CONCLUSION: Earlier studies have demonstrated that hyaluronidase is able to sensitize tumor cells to various anticancer agents. Our studies now demonstrate that this sensitization can occur by a mechanism independent of increased drug penetration. This mechanism is likely to be related to the "anti-adhesive" effect of hyaluronidase, which overrides cell contact-dependent growth inhibition, recruits cells into the cycling pool, and renders tumor cells more sensitive to cytotoxic agents that preferentially kill rapidly dividing cells.
IMPLICATIONS: Other tumor-specific "anti-adhesives" should be explored that can be effective chemosensitizers when used in combination with cell cycle-specific drugs for the treatment of small, solid tumors. [J Natl Cancer Inst 1996; 88: 1285–96]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Magzoub, S. Jin, and A. S. Verkman Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin FASEB J, January 1, 2008; 22(1): 276 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Alaniz, M. G. Garcia, C. Gallo-Rodriguez, R. Agusti, N. Sterin-Speziale, S. E. Hajos, and E. Alvarez Hyaluronan oligosaccharides induce cell death through PI3-K/Akt pathway independently of NF-{kappa}B transcription factor Glycobiology, May 1, 2006; 16(5): 359 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Grantab, S. Sivananthan, and I. F. Tannock The Penetration of Anticancer Drugs through Tumor Tissue as a Function of Cellular Adhesion and Packing Density of Tumor Cells Cancer Res., January 15, 2006; 66(2): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Francia, S. K. Green, G. Bocci, S. Man, U. Emmenegger, J. M.L. Ebos, A. Weinerman, Y. Shaked, and R. S. Kerbel Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents Mol. Cancer Ther., October 1, 2005; 4(10): 1484 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. Lokeshwar, W. H. Cerwinka, T. Isoyama, and B. L. Lokeshwar HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and Suppressor Cancer Res., September 1, 2005; 65(17): 7782 - 7789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Francia, S. Green, and R. S. Kerbel Epigenetic Aspects of Environmentally Mediated "Multicellular" Drug Resistance Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 114 - 118. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Francia, S. Man, B. Teicher, L. Grasso, and R. S. Kerbel Gene Expression Analysis of Tumor Spheroids Reveals a Role for Suppressed DNA Mismatch Repair in Multicellular Resistance to Alkylating Agents Mol. Cell. Biol., August 1, 2004; 24(15): 6837 - 6849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-J. Liang, D.-W. Shen, and M. M. Gottesman Down-Regulation and Altered Localization of {gamma}-Catenin in Cisplatin-Resistant Adenocarcinoma Cells Mol. Pharmacol., May 1, 2004; 65(5): 1217 - 1224. [Abstract] [Full Text]
|
|
|
|
|
|
W. D Stein, T. Litman, T. Fojo, and S. E Bates A Serial Analysis of Gene Expression (SAGE) Database Analysis of Chemosensitivity: Comparing Solid Tumors with Cell Lines and Comparing Solid Tumors from Different Tissue Origins Cancer Res., April 15, 2004; 64(8): 2805 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Green, G. Francia, C. Isidoro, and R. S. Kerbel Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro Mol. Cancer Ther., February 1, 2004; 3(2): 149 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Misra, S. Ghatak, A. Zoltan-Jones, and B. P. Toole Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan J. Biol. Chem., July 3, 2003; 278(28): 25285 - 25288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Green, M. C. I. Karlsson, J. V. Ravetch, and R. S. Kerbel Disruption of Cell-Cell Adhesion Enhances Antibody-dependent Cellular Cytotoxicity: Implications for Antibody-based Therapeutics of Cancer Cancer Res., December 1, 2002; 62(23): 6891 - 6900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Frankel, S. Man, P. Elliott, J. Adams, and R. S. Kerbel Lack of Multicellular Drug Resistance Observed in Human Ovarian and Prostate Carcinoma Treated with the Proteasome Inhibitor PS-341 Clin. Cancer Res., September 1, 2000; 6(9): 3719 - 3728. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Netti, D. A. Berk, M. A. Swartz, A. J. Grodzinsky, and R. K. Jain Role of Extracellular Matrix Assembly in Interstitial Transport in Solid Tumors Cancer Res., May 1, 2000; 60(9): 2497 - 2503. [Abstract] [Full Text]
|
|
|
|
|
|
S. Mueller, E. Cadenas, and A. H. Schönthal p21WAF1 Regulates Anchorage-independent Growth of HCT116 Colon Carcinoma Cells via E-Cadherin Expression Cancer Res., January 1, 2000; 60(1): 156 - 163. [Abstract] [Full Text]
|
|
|
|
|
|
B. J. Maurer, M. A. Ihnat, C. Morgan, J. Pullman, C. O'Brien, S. W. Johnson, J. S. Rasey, and M. M. Cornwell Growth of Human Tumor Cells in Macroporous Microcarriers Results in p53-Independent, Decreased Cisplatin Sensitivity Relative to Monolayers Mol. Pharmacol., May 1, 1999; 55(5): 938 - 947. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. St. Croix, C. Sheehan, J. W. Rak, V. A. Florenes, J. M. Slingerland, and R. S. Kerbel E-Cadherin-dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 J. Cell Biol., July 27, 1998; 142(2): 557 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.-S. Chang Hyaluronidase enhancement of TNF-mediated cell death is reversed by TGF-beta 1 Am J Physiol Cell Physiol, December 1, 1997; 273(6): C1987 - C1994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-S. Chang, N. Pratt, J. Heath, L. Schultz, D. Sleve, G. B. Carey, and N. Zevotek Hyaluronidase Induction of a WW Domain-containing Oxidoreductase That Enhances Tumor Necrosis Factor Cytotoxicity J. Biol. Chem., January 26, 2001; 276(5): 3361 - 3370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wartenberg, F. C. Ling, M. Schallenberg, A. T. Baumer, K. Petrat, J. Hescheler, and H. Sauer Down-regulation of Intrinsic P-glycoprotein Expression in Multicellular Prostate Tumor Spheroids by Reactive Oxygen Species J. Biol. Chem., May 11, 2001; 276(20): 17420 - 17428. [Abstract] [Full Text] [PDF]
|
|